- Home
- NTRA vs TME Comparison
NTRA vs TME Comparison
Compare NTRA & TME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRA
- TME
- Stock Information
- Founded
- NTRA 2003
- TME N/A
- Country
- NTRA United States
- TME China
- Employees
- NTRA N/A
- TME N/A
- Industry
- NTRA Medical Specialities
- TME Broadcasting
- Sector
- NTRA Health Care
- TME Consumer Discretionary
- Exchange
- NTRA Nasdaq
- TME Nasdaq
- Market Cap
- NTRA 18.4B
- TME 21.9B
- IPO Year
- NTRA 2015
- TME 2018
- Fundamental
- Price
- NTRA $148.08
- TME $12.29
- Analyst Decision
- NTRA Strong Buy
- TME Strong Buy
- Analyst Count
- NTRA 17
- TME 6
- Target Price
- NTRA $176.65
- TME $15.00
- AVG Volume (30 Days)
- NTRA 1.6M
- TME 7.6M
- Earning Date
- NTRA 05-08-2025
- TME 05-13-2025
- Dividend Yield
- NTRA N/A
- TME 1.47%
- EPS Growth
- NTRA N/A
- TME 36.77
- EPS
- NTRA N/A
- TME 0.58
- Revenue
- NTRA $1,696,911,000.00
- TME $3,891,027,656.00
- Revenue This Year
- NTRA $15.33
- TME $10.17
- Revenue Next Year
- NTRA $18.50
- TME $10.46
- P/E Ratio
- NTRA N/A
- TME $21.16
- Revenue Growth
- NTRA 56.75
- TME 2.34
- 52 Week Low
- NTRA $83.13
- TME $9.41
- 52 Week High
- NTRA $183.00
- TME $15.77
- Technical
- Relative Strength Index (RSI)
- NTRA 50.83
- TME 41.29
- Support Level
- NTRA $125.38
- TME $12.24
- Resistance Level
- NTRA $152.66
- TME $13.11
- Average True Range (ATR)
- NTRA 8.82
- TME 0.67
- MACD
- NTRA 1.47
- TME -0.18
- Stochastic Oscillator
- NTRA 82.19
- TME 20.24
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
About TME Tencent Music Entertainment Group each representing two
Tencent Music is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.